Trafalgar International (GCAN) Accounts Payables (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Accounts Payables of $7514.0 for Q1 2026, down 6.59% year-over-year from $8044.0 in Q1 2025, and down 11.75% quarter-over-quarter from $8514.0 in Q4 2025.
Trafalgar International (GCAN) Accounts Payables (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Accounts Payables history runs 10 years deep, the most recent figure standing at $7514.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 6.59% year-over-year to $7514.0; the TTM figure through Mar 2026 stood at $7514.0 (down 6.59% YoY), while the FY2025 annual figure was $8514.0, up 8.06% from the prior year.
- Accounts Payables for Q1 2026 stood at $7514.0, down from $8514.0 in the prior quarter.
- The five-year high for Accounts Payables was $16251.0 in Q4 2022, with the low at $3340.0 in Q3 2023.
- The 5-year median for Accounts Payables is $7514.0 (2026), against an average of $8126.2.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 333.56% in 2022, then sank 76.64% in 2023.
- Greater Cannabis Company's Accounts Payables stood at $16251.0 in 2022, then plunged by 62.5% to $6094.0 in 2023, then grew by 29.29% to $7879.0 in 2024, then grew by 8.06% to $8514.0 in 2025, then decreased by 11.75% to $7514.0 in 2026.
- Business Quant data shows GCAN's Accounts Payables at $7514.0 in Q1 2026, $8514.0 in Q4 2025, and $8849.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 7,514.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,514.00 |
| Dec 31, 2025 | 8,514.00 |
| Sep 30, 2025 | 8,849.00 |
| Jun 30, 2025 | 6,793.00 |
| Mar 31, 2025 | 8,044.00 |
| Dec 31, 2024 | 7,879.00 |
| Sep 30, 2024 | 6,418.00 |
| Jun 30, 2024 | 5,259.00 |
| Mar 31, 2024 | 6,259.00 |
| Dec 31, 2023 | 6,094.00 |
| Sep 30, 2023 | 3,340.00 |
| Jun 30, 2023 | 5,340.00 |
| Mar 31, 2023 | 5,993.00 |
| Dec 31, 2022 | 16,251.00 |
| Sep 30, 2022 | 14,297.00 |
| Jun 30, 2022 | 8,346.00 |
| Mar 31, 2022 | 12,955.00 |
| Dec 31, 2021 | 11,705.00 |
| Sep 30, 2021 | 8,442.00 |
| Jun 30, 2021 | 1,925.00 |